Diagnosis pathway for patients with amyotrophic lateral sclerosis: Retrospective analysis of the US Medicare longitudinal claims database

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Williams, James R ^a   Fitzhenry, David ^b   Grant, Lauren ^b   Martyn, Derek ^b   Kerr, Douglas A ^a  

^a BIOGEN   (United States)

^b Trinity Partners LLC   (United States)

Author keywords

Amyotrophic lateral sclerosis; Diagnostic delay; Diagnostic tests; Pre diagnosis; Symptoms

Indexed keywords

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; ELECTROMYOGRAPHY; FEMALE; HUMAN; ICD-9; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MOTOR NERVE CONDUCTION; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SENSORY NERVE CONDUCTION; SWALLOWING;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DATABASES, FACTUAL; DELAYED DIAGNOSIS; FEMALE; HUMANS; INSURANCE CLAIM REPORTING; LONGITUDINAL STUDIES; MALE; MEDICARE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84886736202     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-160     Document Type: Article

References (17)

1. Gordon PH. Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management. CNS Drugs 2011, 25:1-15.
2. Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG. Eurals Consortium: prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009, 10:310-323. 10.3109/17482960802566824, 3515205, 19922118.
3. Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012, 3. CD001447.
4. Cellura E, Spataro R, Taiello AC, La Bella V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2012, 114:550-554. 10.1016/j.clineuro.2011.11.026, 22169158.
5. Chiò A. ISIS survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol 1999, 246(Suppl 3):III1-III5.
6. Chiò A, Bottacchi E, Buffa C, Mutani R, Mora G. PARALS: positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 2006, 77:948-950. 10.1136/jnnp.2005.083402, 2077622, 16614011.
7. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003, 74:1258-1261. 10.1136/jnnp.74.9.1258, 1738639, 12933930.
8. Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff MM, Wokke JH, Van den Berg LH. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005, 65:1264-1267. 10.1212/01.wnl.0000180717.29273.12, 16247055.
9. Kraemer M, Buerger M, Berlit P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2010, 112:103-105. 10.1016/j.clineuro.2009.10.014, 19931253.
10. Srinivasan J, Scala S, Jones HR, Saleh F, Russell JA. Inappropriate surgeries resulting from misdiagnosis of early amyotrophic lateral sclerosis. Muscle Nerve 2006, 34:359-360. 10.1002/mus.20555, 16609978.
11. Yoshor D, Klugh A, Appel SH, Haverkamp LJ. Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosis. Neurosurgery 2005, 57:984-989. 10.1227/01.NEU.0000180028.64385.d3, 16284567.
12. Mitchell JD, Callagher P, Gardham J, Mitchell C, Dixon M, Addison-Jones R, Bennett W, O'Brien MR. Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)-a 20-year review: can we do better?. Amyotroph Lateral Scler 2010, 11:537-541. 10.3109/17482968.2010.495158, 20565332.
13. Center for Medicare & Medicaid Services Medicare program-general information: overview http://www.cms.gov/Medicare/Medicare-General-Information/MedicareGenInfo/index.html?redirect=/MedicareGenInfo/, Center for Medicare & Medicaid Services.
14. US Department of Health and Human Services New high-value data sets and tools http://www.hhs.gov/open/plan/opengovernmentplan/transparency/dataset.html, US Department of Health and Human Services.
15. Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci 2010, 294:81-85. 10.1016/j.jns.2010.03.028, 20452624.
16. Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M. EFNS task force on diagnosis and management of amyotrophic lateral sclerosis: EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol 2012, 19:360-375.
17. Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol 2012, 69:1410-1416. 10.1001/archneurol.2012.254, 22892641.